Atara Biotherapeutics (ATRA) Interest Coverage Ratio (QoQ) (2014 - 2026)
Atara Biotherapeutics (ATRA) Interest Coverage Ratio (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 96.36% |
| Dec 31, 2025 | -19,605.31% |
| Sep 30, 2025 | -531.76% |
| Jun 30, 2025 | -98.60% |
| Mar 31, 2025 | 178.13% |
| Dec 31, 2024 | 34.76% |
| Sep 30, 2024 | -27.31% |
| Jun 30, 2024 | -84.60% |
| Mar 31, 2024 | -63.80% |
| Dec 31, 2023 | 90.43% |
| Sep 30, 2023 | 3.71% |
| Jun 30, 2023 | 7.71% |
| Mar 31, 2023 | 91.30% |
| Dec 31, 2022 | -73,164.81% |
| Sep 30, 2022 | 50.54% |
| Jun 30, 2022 | 98.88% |
| Mar 31, 2022 | 98.81% |
| Dec 31, 2021 | -364,208.26% |
| Sep 30, 2021 | 46.08% |
| Jun 30, 2021 | 34.07% |